Skip to main content

Table 1 Descriptive of the Ethics Committee Activity by Year

From: Primary health care research in COVID-19: analysis of the protocols reviewed by the ethics committee of IDIAPJGol, Catalonia

 

2019

2020

2021

TOTAL

N (%)

223 (29.7)

235 (31.3)

293 (39.0)

751 (100.0)

Study design

 Interventional study

42 (18.8)

43 (18.3)

39 (13.3)

124 (16.5)

 Observational study

155 (69.5)

161 (68.5)

197 (67.2)

513 (68.3)

 Qualitative study

18 (8.1)

18 (7.7)

40 (13.7)

76 (10.1)

 Othersa

8 (3.6)

13 (5.5)

17 (5.8)

38 (5.1)

Funding

 External/Public grant

26 (11.7)

39 (16.6)

52 (17.7)

117 (15.6)

 Internal grant

39 (17.5)

14 (6.0)

9 (3.1)

62 (8.3)

 Private funding

36 (16.1)

34 (14.5)

68 (23.2)

138 (18.4)

 No funding

122 (54.7)

148 (63)

164 (56)

434 (57.8)

PI characteristics

 Gender (Female)

156 (70.0)

152 (64.7)

183 (62.5)

491 (65.4)

 Holds a PhD degree (yes)

78 (34.5)

90 (38.3)

104 (35.5)

272 (36.2)

 Member of a research group (yes)

56 (24.8)

71 (30.2)

76 (25.9)

203 (27)

Professionals

 General Practitioners (GP)

104 (46.6)

106 (45.1)

120 (41.0)

330 (43.9)

 Physicians other than GP

27 (12.1)

34 (14.5)

36 (12.3)

97 (12.9)

 Pediatricians

7 (3.1)

10 (4.3)

4 (1.4)

21 (2.8)

 Physicians (Gynecologist)

2 (0.9)

2 (0.9)

4 (1.4)

8 (1.1)

 Nurse

49 (22.0)

47 (20.0)

63 (21.5)

159 (21.2)

 Other health professionals

18 (8.1)

10 (4.3)

14 (4.8)

42 (5.6)

 Pharmacists

8 (3.6)

7 (3.0)

11 (3.8)

26 (3.5)

 Biostatisticians/IT

0 (0.0)

0 (0.0)

5 (1.7)

5 (0.7)

 Others

3 (1.3)

3 (1.3)

11 (3.8)

17 (2.3)

 Unknown

5 (2.2)

16 (6.8)

25 (8.5)

46 (6.1)

Number of sessions held

12

25

18

55

EC Results

 Approval

185 (83.0)

188 (80.0)

241 (82.3)

614 (81.6)

  Days until approval

   0

47 (25.4)

55 (29.3)

66 (27.4)

168 (27.4)

   1–30

41 (22.2)

54 (28.7)

73 (30.3)

168 (27.4)

   31–90

51 (27.6)

42 (22.3)

75 (31.1)

168 (27.4)

   91–180

30 (16.2)

28 (14.9)

25 (10.4)

83 (13.5)

   > 6 months

16 (8.6)

9 (4.8)

2 (0.8)

27 (4.4)

 Modification required

38 (17.0)

44 (18.7)

51 (17.4)

133 (17.8)

 Withdrawn

0 (0.0)

3 (1.3)

0 (0.0)

3 (0.4)

 Denied

0 (0.0)

0 (0.0)

1 (0.3)

1 (0.1)

Days to be approved (mean, SD)

55 (73.0)

41.5 (65.4)

34.9 (40.6)

42.9 (60.2)

Covid-19 study objective topic

 

86 (41.3)

122 (58.7)

208 (100.0)

 Epidemiology

 

26 (30.2)

24 (19.7)

50 (24.0)

 Pharmacological treatment

 

9 (10.5)

37 (30.3)

46 (22.1)

 Diagnoses tests

 

24 (27.9)

17 (13.9)

41 (19.7)

 Population impact of COVID-19

 

27 (31.4)

44 (36.1)

71 (34.1)

  1. a Others: economist, sociologists, engineer, journalists, geography and history, trade and marketing